Patents by Inventor Jean-Francois R. Ancher

Jean-Francois R. Ancher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-Substituted phenyl-5-aminomethyl oxazolidinones and their method of use
    Patent number: 4526786
    Abstract: N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones are disclosed. These compounds possess antidepressant activity.
    Type: Grant
    Filed: June 16, 1982
    Date of Patent: July 2, 1985
    Assignee: Delalande S.A.
    Inventors: Guy R. Bourgery, Colette A. Douzon, Jean-Francois R. Ancher, Alain P. Lacour, Patrick G. Guerret, Michel Langlois, Phillippe L. Dostert
  • -N-substituted phenyl-5-methoxymethyl-2-oxazolidinones and pharmaceutical compositions containing same
    Patent number: 4517197
    Abstract: A compound of the formula ##STR1## where R is selected from the group consisting of CH.sub.3 --CO--(CH.sub.2).sub.2 --O--, ##STR2## The compounds are useful in treating depression.
    Type: Grant
    Filed: July 29, 1983
    Date of Patent: May 14, 1985
    Assignee: Delalande S.A.
    Inventors: Jean-Francois R. Ancher, Guy R. Bourgery, Philippe L. Dostert, Colette A. Douzon, Patrick G. Guerret, Alain P. Lacour, Michel Langlois
  • Therapeutical use of known 5-aminomethyl oxazolidine-2-one derivatives
    Patent number: 4470993
    Abstract: Method of treating the central nervous system troubles such as the Parkinson's disease and the senescence troubles, generally treated by the B type monoamine oxidase inhibitors, which comprises administering internally to a human being requiring such treatment a therapeutically effective amount of N-aryl 5-aminomethyl oxazolidine-2-one derivatives.
    Type: Grant
    Filed: March 3, 1983
    Date of Patent: September 11, 1984
    Assignee: Delalande S.A.
    Inventors: Jean-Francois R. Ancher, Guy R. Bourgery, Philippe L. Dostert, Colette A. Douzon, Patrick G. Guerret, Alain P. Lacour, Michel Langlois, Margherita Strolin-Benedetti
  • Piperazines and homopiperazines, N-substituted by an aromatic heterocyclic group, and their use in therapeutics
    Patent number: 4459296
    Abstract: There are disclosed piperidinio, piperazino and homopiperazino derivatives wherein there is N-substitution by a heterocyclic compound taken from the group benzimidazole, indole, purine or benzotriazole and to the organic or mineral acid addition salts of these derivatives. The process for preparation of such compounds and their use is also disclosed.
    Type: Grant
    Filed: April 20, 1982
    Date of Patent: July 10, 1984
    Assignee: Delalande S.A.
    Inventors: Jean-Francois R. Ancher, Patrick G. Guerret, Michel Langlois, Jacky A. Tisne-Versailles
  • N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
    Patent number: 4435415
    Abstract: N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones are disclosed. These compounds possess antidepressant activity.
    Type: Grant
    Filed: June 16, 1982
    Date of Patent: March 6, 1984
    Assignee: Delalande S.A.
    Inventors: Guy R. Bourgery, Colette A. Douzon, Jean-Francois R. Ancher, Alain P. Lacour, Patrick G. Guerret, Michel Langlois, Philippe L. Dostert
  • N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
    Patent number: 4413001
    Abstract: N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones are disclosed. These compounds possess antidepressant activity.
    Type: Grant
    Filed: June 16, 1982
    Date of Patent: November 1, 1983
    Assignee: Delalande S.A.
    Inventors: Guy R. Bourgery, Colette A. Douzon, Jean-Francois R. Ancher, Alain P. Lacour, Patrick G. Guerret, Michel Langlois, Philippe L. Dostert
  • Novel derivatives of 3,4,5-trimethoxy cinnamoyl piperazine, their salts, the process for preparing the same and their application in therapeutics
    Patent number: 4368199
    Abstract: 1-substituted-4-(3,4,5-trimethoxy) cinnamoyl piperazine compounds are disclosed. The compounds exhibit a substantial activity of stimulating cardiac contractile force, without affecting the cardiac frequency, and they also exhibit coronary vasodilatory and hypotensive effects.
    Type: Grant
    Filed: January 16, 1981
    Date of Patent: January 11, 1983
    Assignee: Delalande S.A.
    Inventors: Jean-Francois R. Ancher, Alain P. Lacour, Gerard H. Moinet, Jacky A. Tisne-Versailles
  • N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
    Patent number: 4348393
    Abstract: N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones are disclosed. These compounds possess antidepressant activity.
    Type: Grant
    Filed: June 4, 1979
    Date of Patent: September 7, 1982
    Assignee: Delalande S.A.
    Inventors: Guy R. Bourgery, Colette A. Douzon, Jean-Francois R. Ancher, Alain P. Lacour, Patrick G. Guerret, Michel Langlois, Phillippe L. Dostert
  • 3-Parahydroxyphenyl-5-methylether-2-oxazolidinone compounds
    Patent number: 4287351
    Abstract: N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones are disclosed. These compounds possess antidepressant activity.
    Type: Grant
    Filed: February 6, 1980
    Date of Patent: September 1, 1981
    Assignee: Delalande S.A.
    Inventors: Guy R. Bourgery, Colette A. Douzon, Jean-Francois R. Ancher, Alain P. Lacour, Patrick G. Guerret, Michel Langlois, Phillippe L. Dostert
  • Amides derived from carboxyl-5 pyrimidines
    Patent number: 4250178
    Abstract: Compounds for the formula ##STR1## for example, ##STR2## are prepared by reacting ##STR3## with ##STR4## The compounds possess neuroleptic properties.
    Type: Grant
    Filed: February 12, 1979
    Date of Patent: February 10, 1981
    Assignee: Delalande S.A.
    Inventors: Bernard P. Bucher, Jean-Francois R. Ancher, Thierry F. Imbert